• Antiverse raises $9.3M Series A led by Soulmates Ventures
  • Peptris
  • Galux
  • neuropacs
  • Isomorphic Labs
  • Tamarind Bio
  • Bain & Company
Antiverse - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAntiverse
Antiverse logo

Antiverse

0 followers

About Antiverse

Antiverse is a Cardiff, United Kingdom–based biotech company that designs and discovers antibodies using machine learning to tackle challenging drug targets. Their technology aims to move from target identification to functional antibody within about six months, focusing on targets such as GPCRs and ion channels. They combine computational design with state-of-the-art laboratory screening and multiparameter clustering to generate lead candidates with desirable properties. The company emphasizes partnerships with pharmaceutical companies and global drug discovery programs.

Recent News

No recent news for this company.

Recent Deals

Antiverse Raises $9.3M Series A Led by Soulmates Ventures

March 3, 2026

Key Team Members

Murat Tunaboylu

CEO

Key Facts

HQ Location

Cardiff, United Kingdom

Founded

2017

Employees

11 - 50

Status

Private

Website

https://antiverse.io